UBS Group Cuts CVS Health (NYSE:CVS) Price Target to $59.00
CVS Health (NYSE:CVS – Free Report) had its price objective decreased by UBS Group from $62.00 to $59.00 in a research note released on Tuesday morning. UBS Group currently has a neutral rating on the pharmacy operator’s stock. Several other equities analysts also recently weighed in on CVS. Truist Financial dropped their price objective on […]
CVS Health (NYSE:CVS – Free Report) had its price objective decreased by UBS Group from $62.00 to $59.00 in a research note released on Tuesday morning. UBS Group currently has a neutral rating on the pharmacy operator’s stock. Several other equities analysts also recently weighed in on CVS. Truist Financial dropped their price objective on […]
